GYPENOSIDE

/ INGREDIENTS / By
  1. Therapeutic Effect of Gypenoside on Chronic Liver Injury and Fibrosis Induced by CCl4 in Rats
  2. The inhibitory effect of Gypenoside stereoisomers, Gypenoside L and Gypenoside LI, isolated from Gynostemma pentaphyllum on the growth of human lung cancer …
  3. Purification and characterization of Gypenoside-α-l-rhamnosidase hydrolyzing Gypenoside-5 into ginsenoside Rd
  4. Gypenoside induces apoptosis in human Hep3B and HA22T tumour cells.
  5. Gypenoside XVII prevents atherosclerosis by attenuating endothelial apoptosis and oxidative stress: insight into the ERα-Mediated PI3K/Akt pathway
  6. Biotransformation of ginsenoside Rb1 via the Gypenoside pathway by human gut bacteria
  7. Gypenoside inhibits endothelial cell apoptosis in atherosclerosis by modulating mitochondria through PI3K/Akt/Bad pathway
  8. Gypenoside attenuates β amyloid-induced inflammation in N9 microglial cells via SOCS1 signaling
  9. Metabolomic mechanisms of Gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data
  10. Gypenoside XVII alleviates early diabetic retinopathy by regulating Müller cell apoptosis and autophagy in db/db mice
  11. Microbial Conversion of Ginsenoside to Minor Ginsenoside and Gypenoside XVII by Intrasporangium sp. GS603 Isolated from Soil
  12. Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway
  13. Gypenoside protects against myocardial ischemia-reperfusion injury by inhibiting cardiomyocytes apoptosis via inhibition of CHOP pathway and activation of PI3K/Akt …
  14. Chromosome-level genome assembly of Gynostemma pentaphyllum provides insights into Gypenoside biosynthesis
  15. Gypenoside inhibits interleukin‐1β‐induced inflammatory response in human osteoarthritis chondrocytes
  16. Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway
  17. Gypenoside attenuates white matter lesions induced by chronic cerebral hypoperfusion in rats
  18. Gypenoside XVII enhances lysosome biogenesis and autophagy flux and accelerates autophagic clearance of amyloid-β through TFEB activation
  19. Hybrid sequencing of the Gynostemma pentaphyllum transcriptome provides new insights into Gypenoside biosynthesis
  20. Gypenoside inhibits bovine viral diarrhea virus replication by interfering with viral attachment and internalization and activating apoptosis of infected cells
  21. Gypenoside XLIX loaded nanoparticles targeting therapy for renal fibrosis and its mechanism
  22. Gypenoside XLIX, a naturally occurring PPAR-α activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial …
  23. Gypenoside attenuates renal ischemia/reperfusion injury in mice by inhibition of ERK signaling
  24. Effect and mechanism of Gypenoside on the inflammatory molecular expression in high-fat induced atherosclerosis rats
  25. Gypenoside IX suppresses p38 MAPK/Akt/NFκB signaling pathway activation and inflammatory responses in astrocytes stimulated by proinflammatory mediators
  26. Gypenoside inhibits ox-LDL uptake and foam cell formation through enhancing Sirt1-FOXO1 mediated autophagy flux restoration
  27. Gypenoside LI arrests the cell cycle of breast cancer in G0/G1 phase by down-regulating E2F1
  28. Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities
  29. Gypenoside L inhibits proliferation of liver and esophageal cancer cells by inducing senescence
  30. Enhanced production of Gypenoside LXXV using a novel ginsenoside-transforming β-glucosidase from ginseng-cultivating soil bacteria and its anti-cancer property
  31. Enzymatic biotransformation of ginsenoside Rb1 and Gypenoside XVII into ginsenosides Rd and F2 by recombinant β-glucosidase from Flavobacterium …
  32. Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression
  33. Biotransformation of ginsenoside Rb1 to prosapogenins, Gypenoside XVII, ginsenoside Rd, ginsenoside F2, and compound K by Leuconostoc mesenteroides …
  34. Transcriptome-wide analysis of the AP2/ERF transcription factor gene family involved in the regulation of Gypenoside biosynthesis in Gynostemma pentaphyllum
  35. Gypenoside L inhibits autophagic flux and induces cell death in human esophageal cancer cells through endoplasm reticulum stress-mediated Ca2+ release
  36. Gypenoside TN-2 ameliorates scopolamine-induced learning deficit in mice
  37. Gypenoside inhibits RANKL‐induced osteoclastogenesis by regulating NF‐κB, AKT, and MAPK signaling pathways
  38. Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a Gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer …
  39. A bioactive Gypenoside (GP-14) alleviates neuroinflammation and blood brain barrier (BBB) disruption by inhibiting the NF-κB signaling pathway in a mouse …
  40. Highly selective microbial transformation of major ginsenoside Rb1 to Gypenoside LXXV by Esteya vermicola CNU120806
  41. Pharmaceutical efficacy of Gypenoside LXXV on non-alcoholic steatohepatitis (NASH)
  42. Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic …
  43. Gypenoside protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of mitogen-activated protein kinase mediated nuclear factor kappa …
  44. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation
  45. Biotransformation of Gypenoside XVII to compound K by a recombinant β-glucosidase
  46. Gypenoside A protects ischemia/reperfusion injuries by suppressing miR‐143‐3p level via the activation of AMPK/Foxo1 pathway
  47. Gene excavation and expression analysis of CYP and UGT related to the post modifying stage of Gypenoside biosynthesis in Gynostemma pentaphyllum …
  48. A novel natural PPARγ agonist, Gypenoside LXXV, ameliorates cognitive deficits by enhancing brain glucose uptake via the activation of Akt/GLUT4 signaling in db/db …
  49. Monomer Gypenoside LI from Gynostemma pentaphyllum inhibits cell proliferation and upregulates expression of miR‐128‐3p in melanoma cells
  50. Gypenoside LXXV promotes cutaneous wound healing in vivo by enhancing connective tissue growth factor levels via the glucocorticoid receptor pathway
  51. Gypenoside L, Isolated from Gynostemma pentaphyllum, Induces Cytoplasmic Vacuolation Death in Hepatocellular Carcinoma Cells through Reactive-Oxygen …
  52. Compound K producing from the enzymatic conversion of Gypenoside by naringinase
  53. Gypenoside LXXIV ameliorates scopolamine-induced learning deficit in mice
  54. Gypenoside A from Gynostemma pentaphyllum Attenuates Airway Inflammation and Th2 Cell Activities in a Murine Asthma Model
  55. Metabolite profiling of Gypenoside LVI in rat after oral and intravenous administration
  56. Gypenoside ameliorates insulin resistance and hyperglycemia via the AMPK-mediated signaling pathways in the liver of type 2 diabetes mellitus mice
  57. Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer
  58. Attenuation of Aβ25–35-induced parallel autophagic and apoptotic cell death by Gypenoside XVII through the estrogen receptor-dependent activation of Nrf2/ARE …
  59. Gypenoside UL4-Rich Gynostemma pentaphyllum Extract Exerts a Hepatoprotective Effect on Diet-Induced Nonalcoholic Fatty Liver Disease
  60. Analysis of the inhibitory effect of Gypenoside on Na+, K+-ATPase in rats’ heart and brain and its kinetics
  61. Gypenoside XVII, an Active Ingredient from Gynostemma Pentaphyllum, Inhibits C3aR-Associated Synaptic Pruning in Stressed Mice
  62. Genome-Wide Identification of R2R3-MYB Transcription Factors: Discovery of a “Dual-Function” Regulator of Gypenoside and Flavonol Biosynthesis in …
  63. Gypenoside XVII protects against myocardial ischemia and reperfusion injury by inhibiting ER stress–induced mitochondrial injury
  64. Cardioprotective effects of Gypenoside XVII against ischemia/reperfusion injury: Role of endoplasmic reticulum stress, autophagy, and mitochondrial fusion fission …
  65. Enzymatic Biotransformation of Gypenoside XLIX into Gylongiposide I and Their Antiviral Roles against Enterovirus 71 In Vitro
  66. Gypenoside LVI attenuates foam cell formation by promoting cholesterol export and inhibiting inflammation response
  67. Protective effect of Gypenoside LXXV from Gynostemma pentaphyllum against oxidative stress-induced retinal degeneration in vitro and in vivo
  68. Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative …
  69. Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability
  70. Assessment of the hepatocyte protective effects of Gypenoside and its phosphorylated derivative against DHAV-1 infection on duck embryonic hepatocytes
  71. NOX2-mediated TFEB activation and vacuolization regulate lysosome-associated cell death induced by Gypenoside l, a saponin isolated from Gynostemma …
  72. Simultaneous determination of Gypenoside LVI, Gypenoside XLVI, 2α-OH-protopanaxadiol and their two metabolites in rat plasma by LC–MS/MS and its application to …
  73. Gynostemma pentaphyllum and Gypenoside-IV Ameliorate Metabolic Disorder and Gut Microbiota in Diet-Induced-Obese Mice
  74. Preparative separation of Gypenoside XVII, ginsenoside Rd2, and notoginsenosides Fe and Fd from Panax notoginseng leaves by countercurrent chromatography …
  75. Gynostemma pentaphyllum extract and its active component Gypenoside L improve the exercise performance of treadmill-trained mice
  76. Gypenoside A attenuates dysfunction of pancreatic β cells by activating PDX1 signal transduction via the inhibition of miR‐150‐3p both in vivo and in vitro
  77. Influence of Gypenoside on serum lipoprotein and atherosclerosis in Hyperlipidaemia animals
  78. The occurrence of Gypenoside XVII in suspension cell culture of ginseng Panax japonicus var. repens
  79. … glucose at the C-20 position in ginsenosides by β-glucosidase from Thermus thermophilus and its application to the production of ginsenoside F2 from Gypenoside …
  80. Effects of Gypenoside on pancreatic beta cell function and insulin secretion
  81. Inhibitory effects of Gypenoside on rat heart and brain Na+, K+ (-) ATPase activity
  82. Diversity of Endogeny Eumycetes in Gynostemma pentaphyllum and Its Correlation with Gypenoside XLIX
  83. Pharmacokinetics of Gypenoside XVⅡ in rats
  84. Gypenoside granules improved lipid metabolism in C57BL/6J mice with hyperlipidemia
  85. Determination on the glycosyl sequence of Gypenoside A by TLC-FABMS
  86. Gynostemma pentaphyllum extract and Gypenoside L enhance skeletal muscle differentiation and mitochondrial metabolism by activating the PGC-1α …
  87. Gypenoside, the main active compound of Gynostemma pentaphyllum, mitigates the Diabetic Nephropathy through down-regulating mTOR
  88. MEMORY FACILITATION INDUCED BY GYNOSTEMMA PENTAPHYLLUM AND Gypenoside Ⅲ (GINSENOSIDER b_1) IN MICE
  89. Gypenoside XVII Inhibits High Glucose-Induced Apoptosis and Facilitates Osteogenic Differentiation in MC3T3-E1 Cells.
  90. Gypenoside XVII
  91. Effect of Gypenoside on serum uric acid of hyperuricemic rats
  92. Development of a targeted method for quantification of Gypenoside XLIX in rat plasma, using SPE and LC–MS/MS
  93. Identification, isolation and purification of transformed product of Gypenoside XLIX by thermophilic glycosidase Fpendo5A.
  94. Effects of Gypenoside on in vitro ruminal microbial methane production and fermentation characteristics.
  95. Protection of Gypenoside XVII against cerebral ischemia/reperfusion injury across the SIRT1-FOXO3A and Hif1a-BNIP3-mediated mitochondrial autophagy
  96. Development of pre-assessment indicator for skin aging and anti-aging effect of inner skin by the cream product containing Gynostemma pentaphyllum Gypenoside …
  97. Gynosaponin TN-1 producing from the enzymatic conversion of Gypenoside XLVI by naringinase and its cytotoxicity on hepatoma cell lines
  98. Production of Minor Gisenosides from Gypenoside V
  99. Gypenoside alleviates injury of rat adrenal pheochromocytoma cell line PC12 induced by lipopolysaccharide
  100. Protective effects of Gypenoside on cultured bovine aortic endothelial cells against injury induced by oxidatively modified low density lipoprotein
  101. An amino acid at position 512 in β-glucosidase from Clavibacter michiganensis determines the regioselectivity for hydrolyzing Gypenoside XVII
  102. Identification of Gypenoside by using NMR spectroscopy.
  103. Studies on fermentation kinetics of Gypenoside.
  104. HPLC determination of Gypenoside B in Jiaogulan Zonggan capsules
  105. The protective effect of Gypenoside on brainstem ischemia and its mechanism
  106. Technology of extracting Gypenoside from crude Herba Gynostemmae Pentaphylli solution by foaming separation
  107. Preparation of Gypenoside self-microemulsifying drug delivery system.
  108. Influence of Gypenoside on serum lipoprotein and atherosclerosis in hyperlipidaemia animal
  109. Kinetics and effect of Gypenoside-selenium complex on tyrosinase activity
  110. Therapeutic Effect of Gypenoside on Chronic Liver Injury and Fibrosis Induced by CC14 in Rats
  111. Protective effect of Gypenoside on brainstem ischemic injuries in dogs
  112. HPLC Determination of the Content of Longstalk Gypenoside B in Total Longstalk Gypenosides
  113. Effect of Gypenoside on lipopolysaccharide-mediated microglial inflammatory response
  114. Bioconverstion of Gypenoside to Minor Ginsenoside Using Purified Enzyme from Aspergillus sp.
  115. Gypenoside L and Gypenoside LI Inhibit Proliferation in Renal Cell Carcinoma via Regulation of the MAPK and Arachidonic Acid Metabolism Pathways
  116. Protective Effect of Gypenoside on Peripheral Nerve Toxicity Induced by Oxaliplatin in Rats and Its Mechanism
  117. Optimization of the ultrasonic extraction of Gypenoside III from Gynostemma pentaphyllum by response surface methodology
  118. Antagonistic effect of Gypenoside on diaphragm against doxorubicin cytotoxicity
  119. Effect of Gypenoside on c-fos gene expression in cultured aortic muscle cell of rabbit
  120. Transformation of Gypenoside (Gynostemma pentaphyllum saponin) by Enzymes Isolated from Aspergillus niger
  121. Gypenoside regulates long non-coding RNA TUG1/miR-26a by interfering with mitochondrial apoptosis on hepatic lipid deposition of ApoE-/-AS mice
  122. Effects of hormone on the peroxidase and the content of Gypenoside in gynostemma callus
  123. Inhibition of Endoplasmic Reticulum Stress and Mitochondrial Damage Crosstalk by Gypenoside XVII Protects against Myocardial Ischemia and Reperfusion Injury
  124. Extraction of Gypenoside from Gynostemma pentaphyllum (Thunb.) Makino by Dynamic Continuous Countercurrent Technology.
  125. Protection of Gypenoside against oxygen free radical induced vasospasm of isolated rabbit basilar artery
  126. Comparison of Various Preparations of Gynostemma pentaphyllum (Jiaogulan) and its Main Active Constituents, Gypenoside Saponins, on Resting Metabolic Rate …
  127. An experimental study on the antileukemia effects of Gypenosides in vitro and in vivo
  128. Further New Gypenosides from Jiaogulan (Gynostemma pentaphyllum)
  129. Anti-cancer effect and the underlying mechanisms of Gypenosides on human colorectal cancer SW-480 cells
  130. Gypenosides protect retinal pigment epithelium cells from oxidative stress
  131. The direct release of nitric oxide by Gypenosides derived from the herb Gynostemma pentaphyllum
  132. Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation
  133. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP 3 inflammasome activation
  134. Protective effect of Gypenosides against oxidative stress in phagocytes, vascular endothelial cells and liver microsomes
  135. Gypenosides protect primary cultures of rat cortical cells against oxidative neurotoxicity
  136. Mechanism of Gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway
  137. Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-κB …
  138. Hypolipidemic effect of Gypenosides in experimentally induced hypercholesterolemic rats
  139. Mechanism of action of Gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats
  140. Gypenosides induced apoptosis in human colon cancer cells through the mitochondria-dependent pathways and activation of caspase-3
  141. Lipid-lowering, hepatoprotective, and atheroprotective effects of the mixture Hong-Qu and Gypenosides in hyperlipidemia with NAFLD rats
  142. ComMSnDB—An Automatable Strategy to Identify Compounds from MS Data Sets (Identification of Gypenosides as an Example)
  143. Gypenosides reduced the risk of overweight and insulin resistance in C57BL/6J mice through modulating adipose thermogenesis and gut microbiota
  144. … and Characterization of a Novel Terrabacter ginsenosidimutans sp. nov. β-Glucosidase That Transforms Ginsenoside Rb1 into the Rare Gypenosides XVII and LXXV
  145. Gypenosides induced G0/G1 arrest via inhibition of cyclin E and induction of apoptosis via activation of caspases-3 and-9 in human lung cancer A-549 cells
  146. Neuroprotective effects of Gypenosides in experimental autoimmune optic neuritis
  147. Protective effects of Gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats
  148. Gypenosides alleviate myocardial ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function in rat heart
  149. Gypenosides induced G0/G1 arrest via CHk2 and apoptosis through endoplasmic reticulum stress and mitochondria-dependent pathways in human tongue cancer …
  150. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and memory impairment in rats
  151. Gypenosides altered hepatic bile acids homeostasis in mice treated with high fat diet
  152. Uncovering the anti-NSCLC effects and mechanisms of Gypenosides by metabolomics and network pharmacology analysis
  153. Gypenosides improve cognitive impairment induced by chronic cerebral hypoperfusion in rats by suppressing oxidative stress and astrocytic activation
  154. Natural Gypenosides: targeting cancer through different molecular pathways
  155. Cytotoxic activity of Gypenosides and gynogenin against non-small cell lung carcinoma A549 cells
  156. Antidepressant-like effects of standardized Gypenosides: involvement of brain-derived neurotrophic factor signaling in hippocampus
  157. Protection of vascular endothelial cells from hydrogen peroxide‐induced oxidant injury by Gypenosides, saponins of Gynostemma pentaphyllum
  158. Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression
  159. Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFκB and matrix metalloproteinase-9
  160. Gypenosides synergistically enhances the anti-tumor effect of 5-fluorouracil on colorectal cancer in vitro and in vivo: a role for oxidative stress-mediated DNA …
  161. Ameliorating effects of Gypenosides on chronic stress-induced anxiety disorders in mice
  162. The preparation of Gypenosides liposomes and its effects on the peritoneal macrophages function in vitro
  163. Neuroprotective effect of Gypenosides against oxidative injury in the substantia nigra of a mouse model of Parkinson’s disease
  164. Gypenosides as natural emulsifiers for oil-in-water nanoemulsions loaded with astaxanthin: Insights of formulation, stability and release properties
  165. Gypenosides attenuate retinal degeneration in a zebrafish retinitis pigmentosa model
  166. Antiproliferation and anti-migration induced by Gypenosides in human colon cancer SW620 and esophageal cancer Eca-109 cells
  167. Gypenosides induce apoptosis in human hepatoma Huh-7 cells through a calcium/reactive oxygen species-dependent mitochondrial pathway
  168. A combination of grape seed‐derived procyanidins and Gypenosides alleviates insulin resistance in mice and HepG2 cells
  169. The molecular mechanism of Gypenosides-induced G1 growth arrest of rat hepatic stellate cells
  170. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of Gypenosides
  171. Gypenosides prevent H2O2-induced retinal ganglion cell apoptosis by concurrently suppressing the neuronal oxidative stress and inflammatory response
  172. Induction of p53‐independent growth inhibition in lung carcinoma cell A549 by Gypenosides
  173. Effects of Gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson׳ s disease
  174. Molecular evidence of anti-leukemia activity of Gypenosides on human myeloid leukemia HL-60 cells in vitro and in vivo using a HL-60 cells murine xenograft model
  175. Gypenosides protects dopaminergic neurons in primary culture against MPP+-induced oxidative injury
  176. Therapeutic effect of Gypenosides on nonalcoholic steatohepatitis via regulating hepatic lipogenesis and fatty acid oxidation
  177. Gypenosides might have neuroprotective and immunomodulatory effects on optic neuritis
  178. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2-9 and urokinase-plasminogen by …
  179. Chemical composition of tetraploid Gynostemma pentaphyllum Gypenosides and their suppression on inflammatory response by NF‐κB/MAPKs/AP‐1 signaling …
  180. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and anxiety-like behaviors in rats
  181. The synergistic antifungal effects of Gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm …
  182. Hairy root cultures of Gynostemma pentaphyllum (Thunb.) Makino: a promising approach for the production of Gypenosides as an alternative of ginseng saponins
  183. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
  184. Gypenosides protect orbital fibroblasts in Graves ophthalmopathy via anti-inflammation and anti-fibrosis effects
  185. Inhibitory effects of Gypenosides on seven human cytochrome P450 enzymes in vitro
  186. Hypolipidemic mechanism of Gypenosides via inhibition of pancreatic lipase and reduction in cholesterol micellar solubility
  187. Gypenosides suppress growth of human oral cancer SAS cells in vitro and in a murine xenograft model: the role of apoptosis mediated by caspase-dependent and …
  188. In vitro inhibitory activities of six Gypenosides on human liver cancer cell line HepG2 and possible role of HIF-1α pathway in them
  189. Gypenosides inhibits xanthine oxidoreductase and ameliorates urate excretion in hyperuricemic rats induced by high cholesterol and high fat food (lipid …
  190. The immunological adjuvant activity of Gypenosides liposome against Newcastle disease vaccine
  191. Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells
  192. Research on the potential mechanism of Gypenosides on treating thyroid-associated ophthalmopathy based on network pharmacology
  193. Gypenosides pre-treatment protects the brain against cerebral ischemia and increases neural stem cells/progenitors in the subventricular zone
  194. Gypenosides inhibit inflammatory response and apoptosis of endothelial and epithelial cells in LPS-induced ALI: a study based on bioinformatic analysis and …
  195. Method development for Gypenosides fingerprint by high performance liquid chromatography with diode-array detection and the addition of internal standard
  196. Gypenosides Induce Apoptosis by Ca2+ Overload Mediated by Endoplasmic-Reticulum and Store-Operated Ca2+ Channels in Human Hepatoma Cells
  197. Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
  198. Gypenosides mediate cholesterol efflux and suppress oxidized LDL induced inflammation in retinal pigment epithelium cells
  199. Gypenosides ameliorate carbon tetrachloride-induced liver fibrosis by inhibiting the differentiation of hepatic progenitor cells into myofibroblasts
  200. Preparation and characterization of quercetin nanosuspensions using Gypenosides as novel stabilizers
  201. Regulation of Bcl-2 family molecules and activation of caspase cascade involved in Gypenosides-induced apoptosis in human hepatoma cells
  202. Gypenosides attenuate cholesterol‑induced DNA damage by inhibiting the production of reactive oxygen species in human umbilical vein endothelial cells
  203. Gypenosides induce cell death and alter gene expression in human oral cancer HSC‑3 cells
  204. N-acetyltransferase is involved in Gypenosides-induced N-acetylation of 2-aminofluorene and DNA adduct formation in human cervix epidermoid carcinoma cells (Ca …
  205. Gypenosides Alleviate Cone Cell Death in a Zebrafish Model of Retinitis Pigmentosa
  206. Effect of Gypenosides on the composition of gut microbiota and metabolic activity in the treatment of CCl4-induced liver injury in rats
  207. The effect of Gypenosides on cardiac function and expression of cytoskeletal genes of myocardium in diabetic cardiomyopathy rats
  208. Protective effect of Gypenosides on DNA and RNA of rat neurons in cerebral ischemia-reperfusion injury.
  209. Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway
  210. Effects of Gypenosides from Gynostemma pentaphyllum supplementation on exercise-induced fatigue in mice
  211. Unraveling the metabolic pathway of choline-TMA-TMAO: Effects of Gypenosides and implications for the therapy of TMAO related diseases
  212. Effects of Plant Elicitors on Growth and Gypenosides Biosynthesis in Cell Culture of Giao co lam (Gynostemma pentaphyllum)
  213. Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis
  214. Alkaline cleavage of Gypenosides and characterization of dammarane‐type aglycones by gas chromatography–mass spectrometry
  215. Histochemical localization of ginsenosides in Gynostemma pentaphyllum and the content changes of total Gypenosides
  216. Gypenosides inhibit renal fibrosis by regulating expression of related genes in rats with unilateral ureteral obstruction.
  217. Gypenosides, the cancer buster from Gynostemma pentaphyllum (Thunb.) Makino and the apoptotic pathways: a review
  218. Effects of Gypenosides on cellular immunity of γ-ray-irradiated mice
  219. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway
  220. Bronchodilatory effects of the aqueous extract of Gynostemma pentaphyllum and Gypenosides III and VIII in anaesthetized guinea-pigs
  221. Gypenosides attenuate lipopolysaccharide-induced optic neuritis in rats
  222. Effect of Gypenosides on DMN-induced liver fibrosis in rats
  223. Study on quality standard of Gypenosides extract and Gypenosides Tablets
  224. Effects of Gypenosides on mouse splenic lymphocyte transformation and DNA polymerase II activity in vitro.
  225. Therapeutic effects of Gypenosides on hypercholesterolemia and it protective effect on liver injury
  226. Quantification of computational fluid dynamics simulation assists the evaluation of protection by Gypenosides in a zebrafish pain model
  227. The components data of fuzheng huayu extracts, cordyceps sinensis mycelia polysaccharide, Gypenosides and amygdalin
  228. Effects of light quality on growth, total Gypenosides accumulation and photosynthesis in Gynostemma pentaphyllum
  229. Gypenosides regulate autophagy through Sirt1 pathway and the anti-inflammatory mechanism of mitochondrial autophagy in systemic lupus erythematosus
  230. miR-124 antagonizes the antidepressant-like effects of standardized Gypenosides in mice
  231. The Feasibility of Novel Liposome Consisted of Sphingomyelin and β-sitosterol for Gypenosides Delivery
  232. Effects of Gypenosides on PCSK9 gene expression and blood lipids lowered by simvastatin
  233. Research progress on chemical constituents in hydrolyzed products of Gypenosides and their pharmacological activities
  234. Targeting Cancer through PI3K/AKT/mTOR pathway with selected natural products (β-Elemene, Puerarin and Gypenosides)
  235. Gypenosides protected the neural stem cells in the subventricular zone of neonatal rats that were prenatally exposed to ethanol
  236. Protective effect of Gypenosides on cerebral cortex and hippocampus in vascular dementia rat
  237. Effect of Gypenosides on Myocardial Ischemia-Reperfusion Injury and its Mechanism
  238. Study on effect of Gypenosides on insulin sensitivity of rats with diabetes mellitus via regulating NF-κB signaling pathway
  239. Isolation and characterization of Gypenosides from Gynostemma pentaphyllum.
  240. Gypenosides inhibited N-acetylation of 2-aminofluorene, N-acetyltransferase gene expression and DNA adduct formation in human cervix epithelioid carcinoma cells …
  241. Protective effects of Gypenosides on experimental myocardial infarction
  242. Protective effects of Gypenosides on focal brain ischemia-reperfusion injury in rats
  243. Effects of Gypenosides on immune function of rats in vitro
  244. Effects of Gypenosides on acute stress in mice
  245. Gypenosides protect against cardiac ischemia-reperfusion injury by inhibiting mitochondria-dependent apoptosis
  246. Gypenosides protect acute alcoholic liver injury through Nrf2/nf-kb signaling pathway in mice
  247. Effects of Gypenosides on hypoxic pulmonary vasoconstriction in healthy men and anesthetized dogs
  248. Preparation, characteristics and bioactivity of Gypenosides-Loaded microcapsules
  249. Co-administration of berberine/Gypenosides/bifendate ameliorates metabolic disturbance but not memory impairment in type 2 diabetic mice
  250. Conversion of Gypenosides by enzymatic hydrolysis with β-glucanase
  251. Gypenosides modulate NCX calcium flux, insulin secretion and cytoprotection in BRIN-BD11 pancreatic β-cells
  252. Gypenosides inhibits the growth and induces apoptosis of glioma cells by promoting autophagy
  253. Suppressive effect of Gypenosides on murine leukemia l1210 cell lines
  254. Protective effects of Gypenosides on rat hepatic lipid peroxidation and membrane fluidity damage: in vitro studies
  255. Continuous Pressurized Fluid Extraction of Gynostemma pentaphyllum and Purification of Gypenosides
  256. The effect of Gypenosides on leukemia P388 cells and its mechanism study
  257. Evaluating effects of Gypenosides and soyasaponins on differentiation of neural stem cells as an in vitro model
  258. Effect of light quality on total Gypenosides accumulation and related key enzyme gene expression in Gynostemma pentaphyllum
  259. Preparation of novel Gypenosides long-circulating liposomes consisted by sphingomyelin and beta-sitosterol modified by PEG
  260. Effects of Gypenosides to the immune deficit mouse’s non-specific immunological function
  261. Effects of combination of aspirin and Gypenosides on platelet aggregation
  262. Gypenosides protect acute alcoholic liver injury through Nrf2/nf-kb signaling pathway in mice
  263. Gypenosides Prevent H2O2-Induced Retinal Ganglion Cell Apoptosis by Concurrently Suppressing the Neuronal Oxidative Stress and Inflammatory Response
  264. Effects of Gypenosides on monoamine transmitter contents of brain and physical signs in normal and reserpinized mice
  265. Protective effect of Gypenosides on free radical damage of isolated guinea pig papillary muscles
  266. Effect of Gypenosides on RAGE expression and oxidative stress in human mesangial cells induced by AGEs
  267. Protective effect of Gypenosides on cerebral ischemia-reperfusion injury of hippocampus and dentate gyrus of rat
  268. Effects of Gypenosides on Dopaminergic Neuronal Cell Death in 6-Hydroxydopamine-lesioned Rat Model of Parkinson’s Disease with Longterm L-DOPA …
  269. Mechanism by which Gypenosides alleviate oxidative stress injury induced by H2O2 in rat osteoblasts
  270. Effect of Gypenosides on the Prevention and Treatment of Atherosclerosis by Autophagosome
  271. Cytoprotective effects of combination of Gypenosides and Costus pictus D. Don extract in BRIN-BD11 β-cells
  272. Studies on the correlation between the content of Gypenosides and its vegetative organs and growth period
  273. Process Optimization of Extraction and Purification on Gypenosides
  274. Improving the learing and memory ability on aging rats by Gypenosides
  275. Effect of Gypenosides on the Composition of Gut Microbiota and Metabolic Activity in the Treatment of Liver Injury
  276. Influence of Gypenosides on Lewis lung carcinoma
  277. Further New Gypenosides from Jiaogulan (Gynostemma pentaphyllum)
  278. Damages of Gypenosides on the ultrastructures of S-180 Sarcoma in Mouse
  279. THE ULTRASTRUCTURE STUDY ON EFFECTS OF GypenosideS ON PLATELET FUNCTION IN RABBITS
  280. Gypenosides Induce Apoptosis on Human Hepatoma Cells Line
  281. Migration Inhibition Induced by Gypenosides and Its Combination Effect with 5-fluorouracil on Human Colon Cancer SW-620 Cells
  282. The anti-proliferation effect of Gypenosides on cervical cancer HeLa cells and its molecular mechanism
  283. Effects of Gypenosides on chronic stress-induced anxiety in mice
  284. Effect of Gypenosides on the levels of fasting plasma glucose in diabetic rats
  285. Integrated Network Pharmacology and Serum Metabolomics Analysis to Reveal the Mechanism of Gypenosides Against Lung Cancer and Enhancing Cisplatin …
  286. Effects of Gypenosides on Heart Function of Rats with Adriamycin-induced Acute Heart Failure
  287. Effect of Gypenosides on proliferation of neural precursor cells in vitro.
  288. Ameliorating Effects of Gypenosides on Chronic Stress-Induced in Mice
  289. Effects of Gypenosides on contraction of isolated duodenum smooth muscle of rabbits
  290. Protective effect of Gypenosides on local cerebral ischemia injury in rats.
  291. Effects of Gypenosides from gynostemma pentaphyllum on footshock stress in mice
  292. EFFECTS OF GypenosideS ON CELLULAR IMMUNITY OF γ-RAY-IRRADIATED MICE
  293. Protective effects of Gypenosides on PC12 cell injury induced by oxidative stress
  294. Effect of Gypenosides on hepatic function and fibrosis in rats with immune fibrosis
  295. Protective effect of Gypenosides on OFR-induced damage of relaxing capacity of rabbit thoracic aortae in vitro
  296. Study on preparation of Gypenosides liposomes composed of sphingomyelin and cholesterol and its quality evaluation
  297. Study on the Effects of Gypenosides on Gene Expression of Major Urinary Proteins in Hypercholesterolemia Model Mice
  298. Effects of Gypenosides on monoamine oxidase and Na/K-ATPase activities in brain tissues of aging mice
  299. The effect of Gypenosides to antioxidative stress enzyme in the epidermis of photo-damage’s mice.
  300. Correlation studies on the structure and the contents of Gypenosides in vegetative organs of {sl Gynostemma pentaphyllum} in different developmental stages
  301. Conversion of Gypenosides into Minor Ginsenosides by Microbacterium esteraromaticum GS514
  302. Study on the mutagenic and antimutagenic potentials of Gypenosides (GPS) in mice
  303. Effects of Gypenosides on the expressions of p53 and p21 protein in photodamaged BALB/c mouse skin
  304. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and anxiety-like behaviors in rats
  305. The anti-tumor effect and the impact on gut microbiota of Gypenosides Rd and Rb3 in ApcMin/+ mice

Related Posts

Shopping Cart
Scroll to Top